Pharmaceuticals

Global Plasma Protein Therapeutics Market Trends and Growth Analysis 2025–2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Does The Market Size Of The Plasma Protein Therapeutics Industry Compare Between 2025 And 2029?

The plasma protein therapeutics market has experienced significant growth in recent years. It is anticipated to expand from $32.22 billion in 2024 to $34.68 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.6%. Historically, this expansion has been influenced by factors such as the increasing occurrence of rare diseases, a growing elderly demographic, the global availability of blood plasma, an uptick in hemophilia instances, advancements in diagnostic methods, and a favorable regulatory environment.

The plasma protein therapeutics market is projected to experience substantial growth in the coming years, with its size anticipated to reach $45.58 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.1%. This expansion is attributed to factors such as gene therapy advancements, increasing healthcare expenditure, expanded indications, precision medicine approaches, and patient access programs. Significant trends expected during this period include technological innovations, telemedicine adoption, advancements in plasma fractionation technology, the development of next-generation therapies, the adoption of recombinant therapies, and personalized medicine approaches.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9213&type=smp

Which Drivers Are Supporting Growth Of The Plasma Protein Therapeutics Market?

The rising incidence of autoimmune conditions is anticipated to fuel the expansion of the plasma protein therapeutics market in the future. Such a disorder arises when the immune system of the body mistakenly targets and damages its own healthy cells. Therapeutic plasma exchange offers a treatment for these diseases, which manifest when the body incorrectly identifies a component of itself as alien, subsequently generating proteins (termed autoantibodies) that attack this misidentified bodily part. For example, in May 2023, research carried out by the University of Glasgow, a public university located in the UK, surveyed 22 million individuals and revealed that autoimmune disorders impact approximately 10% of the UK’s population, surpassing prior projections. Consequently, the growing prevalence of autoimmune disorders is a key factor propelling the development of the plasma protein therapeutics market moving ahead.

What Are The Major Segment Types Covered In The Plasma Protein Therapeutics Market?

The plasma protein therapeutics market covered in this report is segmented –

1) By Product: Immunoglobulin, Albumin, Coagulation Factor, C1-esterase Inhibitors, Other Products

2) By Route Of Administration: Intravenous, Subcutaneous

3) By Applications: Primary Immunodeficiency Disorder (PID), Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency, Hereditary Angioedema, Other Applications

Subsegments:

1) By Immunoglobulin: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

2) By Albumin: Human Serum Albumin, Recombinant Albumin

3) By Coagulation Factor: Factor VIII, Factor IX, Prothrombin Complex Concentrates

4) By C1-Esterase Inhibitors: Human C1-Esterase Inhibitors, Recombinant C1-Esterase Inhibitors

5) By Other Products: Fibrinogen, Alpha-1 Antitrypsin, Clotting Factor Concentrates

Which Market Trends Are Creating New Opportunities In The Plasma Protein Therapeutics Industry?

Product innovations represent a significant trend gaining traction within the plasma protein therapeutic gaining market. Major companies operating in the plasma protein therapeutic sector are concentrating on developing inventive products to achieve a competitive edge. For illustration, in October 2023, Octapharma AG, a company based in Switzerland, secured approval from European medical authorities for the lyophilized variant of its widely recognized product, octaplasLG. This advanced formulation is specifically engineered for pre-hospital transfusion, thereby furnishing healthcare professionals with a practical and efficacious alternative for managing patients in critical scenarios. The approval emphasizes Octapharma’s unwavering dedication to elevating patient care through ground-breaking solutions in the domain of blood products.

Which Key Players Are Driving Competition In The Plasma Protein Therapeutics Market?

Major companies operating in the plasma protein therapeutics market include CSL Behring LLC, Grifols SA, China Biologic Products Holdings Inc., Takeda Pharmaceutical Company Limited, Baxter International Inc., Kedrion SpA, LFB SA, Emergent BioSolutions Inc., Reliance Life Sciences Private Limited, ADMA Biologics Inc., Prothya Biosolutions BV, Bio Products Laboratory Ltd., Biotest AG, Taibang Biological Group Co Ltd, Octapharma Plasma Inc., New York Blood Center, Green Cross Corporation, China National Biotec Group Company Limited, Kamada Ltd., Australian Red Cross Lifeblood

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/plasma-protein-therapeutics-global-market-report

How Is Plasma Protein Therapeutics Market Demand Varying Across Different Regions?

North America was the largest region in the plasma protein therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma protein therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Plasma Protein Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9213&type=smp

Browse Through More Reports Similar to the Global Plasma Protein Therapeutics Market 2025, By The Business Research Company

Blood Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report

Cancer Biologics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Rituximab Biosimilar Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rituximab-biosimilar-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795